On November 24, 2023, Gain Therapeutics, Inc closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.55 USD | +1.59% | +5.37% | -21.90% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.90% | 46.03M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- GANX Stock
- News Gain Therapeutics, Inc.
- Gain Therapeutics, Inc. announced that it has received $5.000176 million in funding